Skip to content
Evigrade
CriticalImidazole antifungal×HMG-CoA reductase inhibitors (statins)

Updated · Methodology

Mechanism

The enzyme CYP3A4 metabolises simvastatin. Strong inhibitors of this enzyme raise blood levels of simvastatin and its active acid form, and with them the risk of myopathy and rhabdomyolysis (simvastatin summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The miconazole oral gel SmPC calls miconazole a clinically potent CYP3A4 inhibitor. It lists simvastatin and lovastatin among the drugs that must not be combined with oral miconazole, because their levels rise and may cause rhabdomyolysis (miconazole oral gel SmPC, AEMPS). The documents give no study of this pair. With itraconazole, another strong CYP3A4 inhibitor, exposure to the active form of simvastatin rose more than 10-fold (simvastatin SmPC, AEMPS). Patients hold the gel in the mouth and then swallow it. After a 60 mg dose, plasma miconazole levels peak at 31–49 ng/mL, and the half-life is 20–25 hours (miconazole oral gel SmPC, AEMPS). Less than 1% of a cream dose is absorbed (miconazole cream SmPC, AEMPS). Each Spanish vaginal ovule contains 100 mg of miconazole with 300 mg of metronidazole. Their SmPC gives data for 1200 mg miconazole ovules: peak plasma levels more than 100 times lower than after oral or intravenous use (vaginal ovule SmPC, AEMPS).

Symptoms

The main risk is myopathy: muscle pain, tenderness or weakness with creatine kinase (CK) more than 10 times the upper limit of normal (simvastatin summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Myopathy can progress to rhabdomyolysis, a breakdown of muscle, sometimes with acute kidney injury caused by myoglobin in the urine. Very rarely, such cases have been fatal (simvastatin SmPC, AEMPS). The risk is higher at age 65 or over, with uncontrolled hypothyroidism, with kidney impairment and with higher simvastatin doses (simvastatin label, US Food and Drug Administration, FDA).

Management

The combination is contraindicated: the miconazole oral gel summary of product characteristics (SmPC) lists simvastatin among the drugs that must not be combined with oral miconazole (miconazole oral gel SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The gel is held in the mouth and then swallowed, so the ban also applies when it is used for oral or oesophageal candidiasis (miconazole oral gel SmPC, AEMPS). The Spanish and US simvastatin labels contraindicate strong CYP3A4 inhibitors. Miconazole is not among their examples, but the gel SmPC itself calls miconazole a clinically potent inhibitor of this enzyme (simvastatin SmPC, AEMPS, and label, US Food and Drug Administration, FDA; miconazole oral gel SmPC, AEMPS). If treatment with a strong inhibitor cannot be avoided, suspend simvastatin for the whole course (simvastatin SmPC, AEMPS, and FDA label) and consider another statin (simvastatin SmPC, AEMPS). The gel SmPC places the contraindication on statins metabolised by CYP3A4 and gives simvastatin and lovastatin as examples (miconazole oral gel SmPC, AEMPS). The miconazole cream and vaginal ovule SmPCs do not mention statins: according to them, little miconazole reaches the blood and clinically relevant interactions are rare (miconazole cream and vaginal ovule SmPCs, AEMPS). Explain to the patient the risk of myopathy and its signs: unexplained muscle pain, tenderness or weakness (simvastatin SmPC, AEMPS). If muscle pain, weakness or cramps appear, measure creatine kinase (CK). Stop simvastatin if CK is above 5 times the upper limit of normal without strenuous exercise or if myopathy is suspected. With severe muscle symptoms, consider stopping simvastatin even at a lower CK (simvastatin SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Miconazole

Other interactions with Simvastatin